HRP970200A2 - Novel carboxylic acid derivatives, their production and use - Google Patents
Novel carboxylic acid derivatives, their production and useInfo
- Publication number
- HRP970200A2 HRP970200A2 HR19614542.2A HRP970200A HRP970200A2 HR P970200 A2 HRP970200 A2 HR P970200A2 HR P970200 A HRP970200 A HR P970200A HR P970200 A2 HRP970200 A2 HR P970200A2
- Authority
- HR
- Croatia
- Prior art keywords
- production
- carboxylic acid
- acid derivatives
- novel carboxylic
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19614542A DE19614542A1 (de) | 1996-04-12 | 1996-04-12 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP970200A2 true HRP970200A2 (en) | 1998-04-30 |
Family
ID=7791123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR19614542.2A HRP970200A2 (en) | 1996-04-12 | 1997-04-11 | Novel carboxylic acid derivatives, their production and use |
Country Status (23)
Country | Link |
---|---|
US (1) | US6103732A (id) |
EP (1) | EP0892788A1 (id) |
JP (1) | JP2000508325A (id) |
KR (1) | KR20000005366A (id) |
CN (1) | CN1216042A (id) |
AR (1) | AR006593A1 (id) |
AU (1) | AU711293B2 (id) |
BG (1) | BG63202B1 (id) |
BR (1) | BR9708614A (id) |
CA (1) | CA2250764A1 (id) |
CO (1) | CO4900038A1 (id) |
DE (1) | DE19614542A1 (id) |
HR (1) | HRP970200A2 (id) |
ID (1) | ID19050A (id) |
IL (1) | IL126026A0 (id) |
NO (1) | NO311802B1 (id) |
NZ (1) | NZ331704A (id) |
PL (1) | PL329240A1 (id) |
SK (1) | SK127698A3 (id) |
TR (1) | TR199802042T2 (id) |
TW (1) | TW419465B (id) |
WO (1) | WO1997038982A1 (id) |
ZA (1) | ZA973096B (id) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199901416T2 (xx) * | 1996-12-18 | 1999-08-23 | Basf Aktiengesellschaft | Heterosiklik karbonikasit t�revleri. |
US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
KR20010023615A (ko) * | 1997-09-04 | 2001-03-26 | 스타르크, 카르크 | 신규 카르복실산 유도체, 그 제조 및 혼합 eta/etb엔도텔린 수용체 길항제로서의 용도 |
PT1498124E (pt) * | 1997-10-17 | 2007-10-16 | Boehringer Ingelheim Int | Utilização de inibidores do sistema renina-angiotensina |
US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
PT1243262E (pt) * | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
DE60100055T2 (de) * | 2001-03-21 | 2003-07-24 | Schwarz Pharma Ag | Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen |
EA013591B1 (ru) | 2004-04-16 | 2010-06-30 | Шварц Фарма Аг | Применение пептидных соединений для профилактики, облегчения и лечения головной боли и болезненных состояний, связанных с или вызванных распространяющейся кортикальной депрессией (csd) |
PL1781276T3 (pl) * | 2004-08-27 | 2010-11-30 | Ucb Pharma Gmbh | Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
PL2462990T3 (pl) | 2006-06-15 | 2014-05-30 | Ucb Pharma Gmbh | Kompozycja farmaceutyczna obejmująca lakozamid i lewetyracetam o synergistycznym działaniu przeciwdrgawkowym |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
AU2882195A (en) * | 1994-06-27 | 1996-01-19 | Ciba-Geigy Ag | Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides |
-
1996
- 1996-04-12 DE DE19614542A patent/DE19614542A1/de not_active Withdrawn
-
1997
- 1997-04-04 KR KR1019980708088A patent/KR20000005366A/ko not_active Application Discontinuation
- 1997-04-04 US US09/155,948 patent/US6103732A/en not_active Expired - Fee Related
- 1997-04-04 NZ NZ331704A patent/NZ331704A/en unknown
- 1997-04-04 CA CA002250764A patent/CA2250764A1/en not_active Abandoned
- 1997-04-04 EP EP97918109A patent/EP0892788A1/de not_active Withdrawn
- 1997-04-04 SK SK1276-98A patent/SK127698A3/sk unknown
- 1997-04-04 AU AU26364/97A patent/AU711293B2/en not_active Ceased
- 1997-04-04 BR BR9708614A patent/BR9708614A/pt not_active IP Right Cessation
- 1997-04-04 IL IL12602697A patent/IL126026A0/xx unknown
- 1997-04-04 PL PL97329240A patent/PL329240A1/xx unknown
- 1997-04-04 CN CN97193737A patent/CN1216042A/zh active Pending
- 1997-04-04 TR TR1998/02042T patent/TR199802042T2/xx unknown
- 1997-04-04 WO PCT/EP1997/001687 patent/WO1997038982A1/de not_active Application Discontinuation
- 1997-04-04 JP JP9536698A patent/JP2000508325A/ja active Pending
- 1997-04-10 AR ARP970101432A patent/AR006593A1/es not_active Application Discontinuation
- 1997-04-11 ZA ZA973096A patent/ZA973096B/xx unknown
- 1997-04-11 CO CO97018895A patent/CO4900038A1/es unknown
- 1997-04-11 HR HR19614542.2A patent/HRP970200A2/xx not_active Application Discontinuation
- 1997-04-11 TW TW086104674A patent/TW419465B/zh not_active IP Right Cessation
- 1997-04-14 ID IDP971240A patent/ID19050A/id unknown
-
1998
- 1998-09-15 BG BG102770A patent/BG63202B1/bg unknown
- 1998-10-09 NO NO19984713A patent/NO311802B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2250764A1 (en) | 1997-10-23 |
NZ331704A (en) | 2000-06-23 |
TR199802042T2 (xx) | 2000-09-21 |
AU2636497A (en) | 1997-11-07 |
BG102770A (en) | 1999-11-30 |
IL126026A0 (en) | 1999-05-09 |
PL329240A1 (en) | 1999-03-15 |
US6103732A (en) | 2000-08-15 |
AR006593A1 (es) | 1999-09-08 |
NO984713L (no) | 1998-10-09 |
BR9708614A (pt) | 1999-08-03 |
NO984713D0 (no) | 1998-10-09 |
CN1216042A (zh) | 1999-05-05 |
WO1997038982A1 (de) | 1997-10-23 |
SK127698A3 (en) | 2000-03-13 |
ZA973096B (en) | 1998-10-12 |
JP2000508325A (ja) | 2000-07-04 |
TW419465B (en) | 2001-01-21 |
ID19050A (id) | 1998-06-04 |
KR20000005366A (ko) | 2000-01-25 |
BG63202B1 (bg) | 2001-06-29 |
AU711293B2 (en) | 1999-10-07 |
EP0892788A1 (de) | 1999-01-27 |
DE19614542A1 (de) | 1997-10-16 |
CO4900038A1 (es) | 2000-03-27 |
NO311802B1 (no) | 2002-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL332720A1 (en) | Novel derivatives of piperydinketone carboxylic acids, their production and application | |
HU9602339D0 (en) | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof | |
HUP9901312A3 (en) | Novel alfa-hydroxylic acid derivatives, their production and use | |
HUP9902645A3 (en) | Fused-ring carboxylic acid derivatives | |
ZA973002B (en) | Carboxylic acid derivatives medicaments comprising these compounds their use and processes for their production | |
HU9502684D0 (en) | 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkane-carboxylic acid derivatives | |
EP0645391A3 (en) | Aminobenzoic acid derivatives. | |
HRP970199A2 (en) | New carboxylic acid derivatives, their production and use | |
HRP970200A2 (en) | Novel carboxylic acid derivatives, their production and use | |
AU2537695A (en) | Epoxysuccinic acid derivatives, their production and use | |
HUP0000084A3 (en) | 3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them | |
AU2406597A (en) | Thienopyridine derivatives, their production and use | |
AU3695297A (en) | Alfa-amino acid amides, preparation thereof and the therapeutical use thereof | |
HUP0000553A3 (en) | Sixmembered nitrogencontained heteroaromatic carboxylic acid derivatives, pharmaceutical compositions containing them, and their use for producing pharmaceutical compositions | |
ZA967537B (en) | Novel carboxylic acid derivatives, their preparation and use. | |
HUP0000498A3 (en) | Novel calpaines, production and use thereof | |
AU4219397A (en) | Novel protein, its production and use | |
AU688611C (en) | New carboxylic acid derivatives, their preparation and their use | |
AU6280800A (en) | Cycloalkylalkane carboxylic acid amides, the production and use thereof | |
AU669416C (en) | Quinolonecarboxylic acid derivatives, their production and use | |
AU2974695A (en) | Nor-alpha-transbergamotenones, their production and use | |
AU5527190A (en) | Acetalically protected, enantiomer-pure alpha-arylalkane carboxylic acids, their production and use | |
ZA939691B (en) | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives production and use thereof | |
HU9303478D0 (en) | N-substituated aza-bicycloheptane derivatives, their production and use | |
AU682218C (en) | Tetrazole derivatives, their production and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
ODBC | Application rejected |